SunFlora, the international CBD brand and creator of award-winning SUNMED products exclusively sold at Your CBD Store franchise locations, has announced its completion of a seven-month-long ValidCare clinical study. The results display the irrefutable evidence of safe and reliable products offered by the brand. SunFlora and 11 other companies supported the study to provide scientific data on liver toxicity to federal and state legislators including the U.S. Congress and the U.S. Food and Drug Administration (FDA). The preliminary results in the 839 subjects displayed zero instances of liver toxicity or disease.
“We are proud to have been one of the qualifying participants to be included in the ValidCare study that truly supports our mission as a company to provide safe and high-quality hemp-derived products to our customers,” said Marcus Quinn, CEO of SunFlora. “Our research efforts continue to demonstrate our dedication to providing unparalleled products that are safe and effective. We look forward to continuing our work with researchers and reputable partners to showcase our unrivaled SUNMED products that our innovative team creates.”
This study, commissioned and designed in response to the FDA’s request, was created so the FDA could confidently determine the appropriate regulatory path for hemp-derived CBD products. Preliminary findings, according to ValidCare’s team of scientists, show no evidence of liver disease in the 839 participants who ingested oral forms of hemp-derived CBD for a minimum of 60 days. There were also no reported cases of increase in the prevalence of elevated liver function tests.
“As a hemp industry leader, SunFlora is always in search of reputable partnerships with research brands and institutions to provide a clear understanding of product safety and formulation efficacy to further our knowledge,” said Anthony Ferrari, Ph.D., Chief Science Officer of SunFlora. “It’s a pivotal time for the hemp and CBD industry when it comes to regulation, and every brand in the industry is impacted. By working with ValidCare we were able to team up with other competitors to let regulators know how serious we take this challenge, and how important collaboration within this science is. We are currently furthering our relationship with universities and companies like Validcare that will bring our entire industry and SunFlora to a more impactful future.”
SunFlora and other brands that participated in this study provided funding, product, certificates of authenticity, and assisted with the recruitment of adult consumers. ValidCare successfully completed the first portion of the study, compiled and delivered the results to the participating brands and the FDA within six weeks.
“We are pleased to have SunFlora and their SUNMED products participate in this important research study,” said Patrick McCarthy, CEO of ValidCare. “Their commitment to consumer safety is a demonstration of leadership and we look forward to them participating in future research opportunities.”
For more information about the ValidCare study or to partner with SunFlora for future studies, contact Anthony Ferrari, Ph.D. directly at firstname.lastname@example.org or visit www.sunflora.org.